Concepedia

Julia X.C. Cao

JX

Statistics

Publications

6

Citations

576

H-Index

6

Active since

2004

Affiliations

Eli Lilly (United States)(Current)

Ionis Pharmaceuticals (United States)

Eli Lilly (Germany)

Julia X.C. Cao is an author at Eli Lilly (United States) specializing in diabetes mellitus, endocrinology, and glycemic control.

Publications per year

2004–2015

6

Publications

6

Hepatic and glucagon-like peptide-1–mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors

Kyle W. Sloop, Julia X.C. Cao, Angela M. Siesky et al. · Journal of Clinical Investigation · 2004 · 215 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets

Kyle W. Sloop, Francis S. Willard, Martin Brenner et al. · Diabetes · 2010 · 140 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Reduction of Hepatic and Adipose Tissue Glucocorticoid Receptor Expression With Antisense Oligonucleotides Improves Hyperglycemia and Hyperlipidemia in Diabetic Rodents Without Causing Systemic Glucocorticoid Antagonism

Lynnetta M. Watts, Vara Prasad Manchem, Thomas A. Leedom et al. · Diabetes · 2005 · 137 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo

Timothy B. Durham, James L. Toth, Valentine J. Klimkowski et al. · Journal of Biological Chemistry · 2015 · 51 citations · Full text

Life Sciences, Biochemistry, Endocrinology +14

Specific Reduction of Hepatic Glucose 6-Phosphate Transporter-1 Ameliorates Diabetes while Avoiding Complications of Glycogen Storage Disease

Kyle W. Sloop, Aaron D. Showalter, Amy L. Cox et al. · Journal of Biological Chemistry · 2007 · 19 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

1–5 of 6